BMY FY 2023 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$124B

FY 2023 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$45.0B-2.5% YoY

Gross Profit

$25.4B56.3% margin

Operating Income

$8.5B18.8% margin

Net Income

$8.0B17.8% margin

EPS (Diluted)

$3.86

Cash Flow

Operating Cash Flow

$13.9B

Free Cash Flow

$12.7B

Stock-Based Comp.

$518M

Balance Sheet

Total Assets

$95.2B

Total Liabilities

$65.7B

Stockholders' Equity

$29.4B

Cash & Equivalents

$11.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45.0B	$46.2B	-2.5%
Gross Profit	$25.4B	$26.5B	-4.3%
Operating Income	$8.5B	$9.3B	-8.6%
Net Income	$8.0B	$6.3B	+26.8%